Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

  Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…

Continue Reading Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia
Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing
Fotorech / Pixabay

Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing

According to a story from Pulmonary Hypertension News, the drug developer United Therapeutics recently issued a statement in which the company announced that it was ceasing the development of esuberaprost…

Continue Reading Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing

ISMRD International Conference for Glycoprotein Storage Diseases Coming This July

Upcoming Conference The International Society for Mannosidosis & Related Diseases (ISMRD) serves as an international patient advocate for those living with glycoprotein storage diseases. These include alpha-mannosidosis, fucosidosis, mucolipidosis type…

Continue Reading ISMRD International Conference for Glycoprotein Storage Diseases Coming This July
Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis
stux / Pixabay

Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

According to a story from AJC, three year old Reid Peteet is one of over 550 kids that have been diagnosed with acute flaccid myelitis since 2014. 2018 saw a…

Continue Reading Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment

For years FibroGen has been investigating a drug called pamrevlumab. They believe it could be an effective treatment for Duchenne muscular dystrophy (DMD), pancreatic cancer, and idiopathic pulmonary fibrosis (IPF).…

Continue Reading Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment
Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis
Source: Pixabay.com

Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis

According to a press release from American biotechnology company Intercept Pharmaceuticals, the company recently released additional data supporting its phase 3 clinical trial of obeticholic acid (OCA) in the treatment…

Continue Reading Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis
Close Menu